Company Predictive Technology Group, Inc. Other OTC
Equities
PRED
US74039H1023
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Human Cell and Tissue Products
99.2
%
| 43 | 99.9 % | 24 | 99.2 % | -44.21% |
Diagnostics & Therapeutics
0.8
%
| 0 | 0.1 % | 0 | 0.8 % | +319.64% |
Sales per region
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 43 | 100.0 % | 24 | 100.0 % | -43.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bradley Robinson
CEO | Chief Executive Officer | 55 | 30/15/30 |
Rakesh Chettier
PRN | Corporate Officer/Principal | - | - |
Douglas Rabin
PRN | Corporate Officer/Principal | - | 04/19/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Robinson
CEO | Chief Executive Officer | 55 | 30/15/30 |
Chairman | 69 | 30/18/30 | |
Ronald Barhorst
BRD | Director/Board Member | 67 | 19/19/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 299,596,808 | 299,596,808 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Predictive Technology Group, Inc.
615 Arapeen Drive Suite 300
84108, Salt Lake City
+
http://www.predtechgroup.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.34% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |